Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
4.55T | 4.40T | 3.98T | 3.11T | 2.49T | 2.55T | Gross Profit |
1.54T | 1.51T | 1.33T | 1.06T | 864.14B | 884.90B | EBIT |
389.66B | 392.14B | 377.03B | 316.35B | 238.62B | 265.51B | EBITDA |
615.65B | 645.76B | 559.26B | 464.41B | 372.22B | 394.00B | Net Income Common Stockholders |
243.15B | 260.31B | 257.75B | 217.71B | 156.25B | 170.73B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
442.80B | 737.96B | 617.66B | 817.62B | 736.10B | 370.79B | Total Assets |
2.57T | 4.88T | 4.30T | 3.82T | 3.24T | 2.67T | Total Debt |
555.90B | 968.18B | 887.63B | 824.81B | 751.21B | 553.80B | Net Debt |
113.10B | 230.22B | 269.96B | 7.20B | 15.11B | 183.01B | Total Liabilities |
1.17T | 2.19T | 2.02T | 1.82T | 1.54T | 1.20T | Stockholders Equity |
1.37T | 2.64T | 2.24T | 1.97T | 1.67T | 1.44T |
Cash Flow | Free Cash Flow | ||||
263.28B | 156.93B | -16.18B | 130.97B | 269.72B | 204.07B | Operating Cash Flow |
507.98B | 399.57B | 158.90B | 245.07B | 374.69B | 302.17B | Investing Cash Flow |
-233.49B | -227.19B | -229.79B | -180.79B | -159.67B | -156.19B | Financing Cash Flow |
-211.83B | -129.62B | -113.09B | -48.70B | 98.94B | -169.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $31.67B | 18.72 | 9.39% | 1.51% | 2.87% | -3.21% | |
77 Outperform | $53.74B | 31.08 | 9.80% | 1.92% | -4.53% | -14.72% | |
70 Outperform | $52.46B | 129.36 | 27.44% | 1.31% | 8.62% | 163.53% | |
69 Neutral | $19.46B | 24.26 | 142.12% | 0.83% | 7.21% | 36.45% | |
68 Neutral | $76.63B | 30.39 | 35.88% | 1.01% | 12.22% | 28.13% | |
62 Neutral | $8.08B | 13.63 | 3.82% | 3.13% | 3.58% | -14.35% | |
61 Neutral | $6.46B | 39.28 | 21.61% | 0.54% | 2.75% | -5.43% |